Lv1
48 积分 2025-09-21 加入
Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)
1天前
待确认
Recent Advances in Automated Structure-Based De Novo Drug Design
2天前
已完结
The changing landscape of medicinal chemistry optimization
3天前
已完结
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use
4天前
已完结
Pharmacophore modeling and its applications
8天前
已完结
Role of Pharmacophores in Virtual Screening and Drug Discovery
8天前
已关闭
Perspectives on current approaches to virtual screening in drug discovery
10天前
已完结
S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2
10天前
已完结
An Analysis of Successful Hit-to-Clinical Candidate Pairs
19天前
已完结
Traf2- and Nck-interacting kinase inhibitors: a patent review (2008–2024)
19天前
已完结
皖公网安备34019202002308
